In yesterday’s Wall Street session, Elanco Animal Health Inc (NYSE:ELAN) shares traded at $12.29, up 0.99% from the previous session.
ELAN stock price is now -0.79% away from the 50-day moving average and -12.60% away from the 200-day moving average. The market capitalization of the company currently stands at $6.08B.
With the price target of $18, UBS recently initiated with Buy rating for Elanco Animal Health Inc (NYSE: ELAN). On December 02, 2024, Leerink Partners recently initiated its ‘Market Perform’ rating on the stock quoting a target price of $14, while ‘Morgan Stanley’ rates the stock as ‘Equal-Weight’
In other news, Harrington Michael J, Director bought 3,500 shares of the company’s stock on Aug 22 ’24. The stock was bought for $51,974 at an average price of $14.85. Upon completion of the transaction, the Director now directly owns 81,094 shares in the company, valued at $1.0 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 12 ’24, PRESIDENT, CEO AND DIRECTOR Simmons Jeffrey N bought 100,000 shares of the business’s stock. A total of $1,300,610 was incurred on buying the stock at an average price of $13.01. This leaves the insider owning 145,000 shares of the company worth $1.78 million. A total of 1.49% of the company’s stock is owned by insiders.
During the past 12 months, Elanco Animal Health Inc has had a low of $11.11 and a high of $18.80. As of last week, the company has a debt-to-equity ratio of 0.67, a current ratio of 2.55, and a quick ratio of 1.31. According to the stock market information, the enterprise value for the company is $9942595584, which is based on a 30.08 price-to-earnings ratio, a 5.58 price-to-earnings-growth ratio, and a beta of 1.42. The fifty day moving average price for ELAN is $12.4264 and a two-hundred day moving average price translates $14.074 for the stock.
The latest earnings results from Elanco Animal Health Inc (NYSE: ELAN) was released for 2024-09-30. The net profit margin was 4.60% and return on equity was 3.24% for ELAN. The company reported revenue of $1.03 billion for the quarter, compared to $1.07 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -3.56 percent.
